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Dendritic cells (DCs) play a central role in initiating adaptive immunity. Murine gammaherpesvirus-68 (MHV-68), like many
persistent viruses, infects DCs during normal host colonization. It therefore provides a means to understanding what host and
viral genes contribute to this aspect of pathogenesis. The infected DC phenotype is likely to depend on whether viral gene
expression is lytic or latent and whether antigen presentation is maintained. For MHV-68, neither parameter has been well
defined. Here we show that MHV-68 infects immature but not mature bone marrow-derived DCs. Infection was predominantly
latent and these DCs showed no obvious defect in antigen presentation. Lytically infected DCs were very different. These
down-regulated CD86 and MHC class I expression and presented a viral epitope poorly to CD8
+ T cells. Antigen presentation
improved markedly when the MHV-68 K3 gene was disrupted, indicating that K3 fulfils an important function in infected DCs.
MHV-68 infects only a small fraction of the DCs present in lymphoid tissue, so K3 expression is unlikely to compromise
significantly global CD8
+ T cell priming. Instead it probably helps to maintain lytic gene expression in DCs once CD8
+ T cell
priming has occurred.
Citation: Smith CM, Gill MB, May JS, Stevenson PG (2007) Murine Gammaherpesvirus-68 Inhibits Antigen Presentation by Dendritic Cells. PLoS
ONE 2(10): e1048. doi:10.1371/journal.pone.0001048
INTRODUCTION
Persistent viruses commonly infect dendritic cells (DCs); epidemic
viruses seem to do so more rarely. The pivotal role DCs play in
initiating anti-viral immunity means that virus-infected DCs
potentially elicit a rapid and potent immune attack [1,2]. Thus,
why persistent viruses should infect them is not clear. The chance
to exploit DC functions presumably offers a selective advantage
that outweighs the risk of greater immunogenicity. A key factor in
the cost/benefit balance of DC infection is MHC class I-restricted
antigen presentation. Viral evasion proteins are therefore likely to
be important in infected DCs both to promote DC survival and to
off-set the increased opportunities for immune priming.
Gamma-herpesviruses infect lymphocytes and therefore have
a particularly intimate relationship with host immune function.
Murine gamma-herpesvirus-68 (MHV-68) is a natural murid
parasite [3] related to the Kaposi’s Sarcoma-associated Herpes-
virus (KSHV) [4]. Like KSHV [5], MHV-68 infects epithelial
cells, B cells, macrophages and DCs [6]. Both viruses inhibit MHC
class I-restricted antigen presentation [7]. The MHV-68 K3
ubiquitinates MHC class I heavy chains [8,9] and TAP [10]. The
KSHV K3 and K5 function similarly [11,12] to down-regulate
a range of immune signalling molecules, including MHC class I
[7,13,14], ICAM-1 and CD86 [15]. Gamma-herpesviruses match
their CD8
+ T cell evasion to specific gene expression programs.
Thus MHV-68, like Epstein-Barr virus [16,17], evades antigen
presentation in cis during episome maintenance [18] when K3 is
probably not transcribed [19]. Proliferating, latently infected
germinal centre B cells do transcribe K3, and K3 disruption causes
a CD8-dependent defect in viral latency amplification [20].
Latency-associated K3 expression has now also been identified
for KSHV [21]. Transactivation of the MHV-68 K3 promoter by
the ORF50 lytic switch protein [22] suggests that K3 has an
another important and as yet undefined function in lytic infection.
MHV-68-infected DCs transcribe K3 and appear to support
a mixture of lytic and latent infection [23]. Thus, K3 is made
either in latently infected DCs or when their virus reactivates.
MHV-68 infects DCs when primed, virus-specific CD8
+ T cells
are abundant [24]. Such CD8
+ T cells normally eliminate DCs
that present viral antigens [25]. K3 may therefore be important for
the survival of lytically infected DCs. Because MHV-68-infected
mice contain very few recoverable infected DCs [23], in vitro
analysis is necessary to define cell phenotypes. A key task is to
distinguish lytic from latent infection. Viral gene expression differs
radically between these states, so it should not be surprising if DC
phenotypes did too.
Distinguishing lytic and latent infections in mixed cultures
depends critically on suitable assays. Lytic and latent infections of
ex vivo cells are typically distinguished by disrupting cells or not to
stop reactivation, and then co-culturing them with permissive
fibroblasts [23,26]. Such assays depend on infectious virions being
sparse, and become problematic when large amounts of pre-
formed infectious virus have been added to in vitro cultures. PCR-
based quantitation is similarly prone to be confounded by input
virus and infected cell debris. A second problem is that such assays
detect only population averages. Thus, they cannot distinguish
which cells are responsible for what effects in mixed populations.
Non-responsive cells may consequently be missed because those
making measurable responses dominate the readout. For example,
a few latently infected or uninfected DCs may secrete a lot of
cytokines while lytically infected DCs secrete none.
Flano et al. [27] have concluded that K3 does not function in
MHV-68-infected DCs. However, they did not distinguish lytic
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- and K3
+
viruses, and did not establish whether the virus they used even
retained K3-such immune evasion functions are frequently lost
with in vitro passage. We have examined DC antigen presentation
by distinguishing lytic from latent infections and comparing K3
2
and K3
+ viruses. We find that MHV-68 markedly down-regulates
antigen presentation in lytically infected DCs and that this is
largely if not entirely dependent on K3. MHV-68 also down-
regulated CD86 expression by a K3-independent mechanism.
Lytically and latently infected DCs were phenotypically very
different. Mature DCs appeared to resist infection altogether.
Besides demonstrating that CD8
+ T cell evasion has an important
function in MHV-68-infected DCs, our data highlight the
problems associated with drawing conclusions from mixed infected
cultures, and suggest that some of the phenotypes reported for
MHV-68-exposed DCs need to be re-examined.
MATERIALS AND METHODS
Cells
BHK-21 cells, NIH-3T3-CRE cells [20] and the 49100.2 T cell
hybridoma [28], which recognizes an H2-D
b-restricted immuno-
dominant MHV-68 peptide derived from ORF6 [24] were
propagated in DMEM with 100 U/ml penicillin, 100 mg/ml
streptomycin, 2 mM glutamine and 10% fetal calf serum.
Dendritic cells were grown from bone marrow progenitors of
C57BL/6 or BALB/c mice in RPMI with 10% fetal calf serum,
50 mM 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml
streptomycin and 7.5 ng/ml GM-CSF (PeproTech, Rocky Hill,
NJ). Both gave similar results. Bone marrow cells were first plated
onto tissue culture plastic (30 min, 37uC) and the adherent
(macrophage-rich) cells discarded. The remaining cells were
cultured, changing the medium every 2 d. After 3 d, non-adherent
(granulocyte-rich) cells were discarded. After 7 d, the non-adherent
cells (90% CD11c
+IA
+Gr1
2) were harvested. Consistent levels of
maturity and responsiveness to maturation signals were confirmed
for each DC population by flow cytometric staining for CD11c,
CD86 and MHC class II with or without prior LPS treatment. We
also established that the cells were negative for the granulocyte
marker GR1. CD4
+ T cells specific for IA
d plus ovalbumin residues
323–339 were harvested from lymph nodes of DO.11.10 transgenic
mice [29]. CD8
+ T cells specific for H2-K
b plus ovalbumin residues
257–264 were harvested from lymph nodes of OT-I transgenic mice
[30], kindly provided by Prof. D. Fearon.
Viruses
All viruses were derived from a cloned MHV-68 BAC [31]. The
gM-eGFP mutant has been described [32]. The MHV-68 K3 gene
was disrupted on this background by digesting a SacI genomic
clone (genomic co-ordinates 21383–28336) [33] with NruI (24851)
and BsmI (24999). The BsmI-cut 59 overhang was filled in with
Klenow fragment DNA polymerase (New England Biolabs,
Hitchin, U.K.) and the 2 blunt ends ligated together. The mutant
SacI clone was then subcloned into the SacI site of pST76K-SR
and recombined into the gM-eGFP
+ MHV-68 BAC by standard
methods [31]. The eGFP coding sequence was fused to the 59 end
of ORF73 by first PCR amplifying ORF73 with 59 EcoRI and 39
XhoI restriction sites in the respective primers and cloning the
PCR product into the EcoRI/SalI sites of pEGFP-C2 (Clontech).
A genomic segment (co-ordinates 104869–106108) corresponding
to the region upstream of ORF73 and incorporating its splice
acceptor site [34] was then amplified by PCR using NheI-
restricted primers and cloned into the NheI sites of the same
vector. The eGFP coding sequence with its 2 genomic flanks was
then subcloned as a blunted fragment into the SmaI site of
pST76K-SR and recombined into the MHV-68 BAC as before.
Infectious viruses were reconstituted by transfecting BAC DNA
into BHK-21 cells with Fugene-6 (Roche Diagnostics Ltd., Lewes,
U.K.). Except when eGFP expression from the BAC cassette was
used as a marker of infection (BAC-eGFP), the loxP-flanked
cassette was removed by virus passage in NIH-3T3-CRE cells
[20]. All viruses were grown in BHK-21 cells. Infected cultures
were cleared of infected cell debris by low-speed centrifugation
(10006g, 3 min). Virions were then concentrated from super-
natants by high speed centrifugation (380006g, 90 min). Virus
titers were determined by plaque assay on BHK-21 cells [35].
Southern Blotting
Viral DNA was isolated from infected BHK-21 cells by alkaline
lysis, phenol/chloroform extraction and salt/ethanol precipitation
[35], digested with BamHI or ApaI, electrophoresed on a 0.8%
agarose gel and transferred to positively charged nylon membranes
(Roche Diagnostics). A
32P-dCTP-labelled probe (APBiotech,
Little Chalfont, U.K.) was generated from either HinDIII
(21965–26711) or BamHI (49938–59884) genomic fragments
[36] by random primer extension (Nonaprimer kit, Qbiogene,
Bingham, U.K.). Membranes were hybridised with probe (65uC,
18 h), washed to a stringency of 0.2% SSC, 0.1% SDS and
exposed to X-ray film.
Antigen presentation assays
To assay MHC class II-restricted presentation of soluble
ovalbumin, DCs (2.5610
5/well) were infected or not (3PFU/cell,
24 h) with MHV-68, then pulsed for 2 h with ovalbumin (Sigma
Chemical Co., Poole, U.K.). The cells were then washed and
DO.11.10 lymph node cells added (10
6/well). Supernatants were
harvested 15 h later and assayed for IL-2 by ELISA (BD-
Pharmingen, Kidlington, U.K.). To assay MHC class I-restricted
presentation of soluble ovalbumin, DCs (2.5610
5/well) were
infected or not (3PFU/cell, 24 h) with MHV-68, then pulsed for
6 h with ovalbumin. The cells were washed and CFSE-labelled
(5 mM, 15 min) OT-I lymph node cells added (10
6/well). The
CD8
+ T cells were harvested 72 h later and assayed for CFSE
content by flow cytometry. To assay MHC class I-restricted
presentation of the H2-D
b-restricted MHV-68 p56 epitope [24],
DCs (2.5610
5/well) were infected or not with MHV-68 (3PFU/
cell, 4 h) and pulsed or not with 20 nM p56 peptide, washed and
then incubated (18 h) with p56-specific 49100.2 T cells. The cells
were then washed in PBS and lysed in PBS/5 mM MgCl2/1%
NP-40/0.15 mM chlorophenol-red-beta-D-galactoside (Merck
Biosciences, Nottingham, U.K.) to assay beta-galactosidase
activity. After 2–4 h the absorbance at 595 nm was read on
a Biorad Benchmark Microplate Reader.
Immunfluorescence
Non-adherent DCs were plated onto poly-D-lysine coated cover-
slips after 7 days of culture, infected or not with MHV-68, then
washed with PBS and fixed with 4% PFA for 10 min. The cells
were then permeabilized with 0.1% Triton-X-100 for 10 min,
blocked for 1 h with 3% BSA and stained for 2 h with MHV-68-
specific monoclonal antibodies plus Alexa Fluor 568-conjugated
anti-mouse IgG pAb (Invitrogen), or with the MHC class II-
specific mAb M5/114 plus Alexa Fluor 568 anti-rat IgG pAb
(Invitrogen). EGFP fluorescence was visualized directly. The
MHV-68-specific mAbs used were MG-12B8 (anti-ORF65 capsid
component) [32], 3F7 (anti-gN) [37], CS1-4A5 (anti-thymidine
kinase) and BN-3H8 (anti-ORF75a). The cells were mounted in
MHV-68 in DCs
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were taken on a Leica Confocal microscope at 636magnification.
Flow cytometry
DCs were detached from tissue culture plates by pipetting, washed
in PBS, blocked with 3% BSA plus an anti-CD16/32 mAb, then
stained for 30 min for CD11c (APC-conjugated mAb N418), plus
either IA
b (PE-conjugated mAb AF6-120.1), CD80 (PE-conjugat-
ed mAb 16-10A1) or CD86 (PE-conjugated mAb GL1) (all from
BD-Biosciences). H2-D
b was detected with mAb 28.14.8 plus PE-
conjugated goat anti-mouse IgG pAb. The cells were analyzed on
a FACS Calibur using Cellquest (BD-Biosciences). Dead cells were
excluded by propidium iodide staining (1 mg/mL).
RESULTS
Identification of dendritic cell infection by viral
eGFP expression
DCs were grown from bone marrow precursors by standard
methods (Fig. 1A). BAC-derived MHV-68 retaining its loxP-
flanked BAC cassette [31] includes eGFP under a human
cytomegalovirus (HCMV) IE-1 promoter (BAC-eGFP); such
HCMV IE-1 promoter-driven gene expression is often used to
track herpesvirus infections. We compared this infection marker
with MHV-68 carrying an eGFP tag on the endogenous gM C-
terminus (gM-eGFP) [32,38] (Fig. 1B). Using an infection
multiplicity of 3PFU/cell, approximately 20% of CD11c
+ DCs
were BAC-eGFP
+ after 18 h and approximately 30% of CD11c
+
cells were gM-eGFP
+.
MHV-68 infection of fibroblasts is highly sensitive to inhibition
by soluble heparin [35,39]. Heparin also blocked gM-eGFP
expression in DCs (Fig. 1C), as did an MHV-68-immune rabbit
serum [26] or phosphonoacetic acid, which inhibits viral late gene
expression (Fig. 1C). DC infection therefore proceded by
a glycosaminoglycan-dependent pathway much like that described
for fibroblasts and epithelial cells [35,39].
gM-eGFP expression but not HCMV IE1 promoter-
driven eGFP expression marks DCs as lytically
infected
We wanted first to establish whether a given DC was lytically or
latently infected. We therefore correlated virus-driven eGFP
expression with capsid distribution. Incoming MHV-68 capsids
migrate to the nuclear margin but remain perinuclear, whereas
newly expressed capsids assemble inside the nucleus [32]. As with
other herpesviruses [40], secondary envelopment and mature
virion egress are rapid, so new MHV-68 capsids in the cytoplasm
are rare [35]. Thus, punctate, perinuclear ORF65 capsid staining
reflects input virions, which may establish either lytic or latent
infection, while strong intranuclear ORF65 staining reflects lytic
infection [32,38]. BAC-eGFP expression in DCs did not correlate
with nuclear ORF65 staining (Fig. 2A). Arrow A shows strong
eGFP expression in a lytically infected DC, arrow B shows very
weak eGFP expression in a lytically infected DC, and arrow C
shows a DC with strong eGFP expression but only input capsids.
BAC-eGFP
2 cells with perinuclear capsids were also evident and
each staining pattern was common (.10% of all MHV-68-
exposed DCs). These data were consistent with MHV-68 infected
macrophages being either BAC-eGFP
+ or BAC-eGFP
2 when
supporting either lytic or latent viral gene expression [38].
In contrast, gM-eGFP
+ cells invariably showed nuclear capsid
staining (Fig. 2A). At 4h post-infection, almost all DCs contained
perinuclear capsids. They had evidently also endocytosed eGFP-
labelled gM (Fig. 2B, arrows A and B). The different distributions
of capsid and gM-eGFP were consistent with a post-fusion
migration of capsids towards nuclear pores [32]. No cells showed
nuclear capsid staining at 4 h post-infection. After 24 h, nuclear
capsid staining was evident in cells that showed strong gM-eGFP
expression (arrow C). Capsid staining in gM-eGFP
2 cells
remained perinuclear, consistent with latent infection (arrow D).
Since gM is a late gene product, it might be argued that BAC-
eGFP expression could reflect early lytic infection. However, it
showed no obvious correlation - either positive or negative - with
staining for ORF75a (Fig. 2C), an early gene product [41]. Some
DCs expressed both BAC-eGFP and ORF75a, but as illustrated in
Fig. 2C, BAC-eGFP
- cells with nuclear ORF75a staining (arrow A)
and BAC-eGFP
+ cell without ORF75a staining (arrow B) were
both abundant. In contrast, all gM-eGFP
+ cells were also
ORF75a
+ (Fig. 2C, arrow C). Approximately 10% of ORF75a
+
cells expressed little gM-eGFP (Fig. 2C, arrow D). These were
presumably in early lytic infection. In addition to ORF65 and
ORF75a, gM-eGFP expression correlated well with gN and
thymidine kinase expression in infected DCs (Fig. 2D), while BAC-
eGFP expression correlated with neither (data not shown).
In summary, DCs infected with BAC-eGFP MHV-68 could be
eGFP
+ or eGFP
2 when expressing lytic gene products and eGFP
+
or eGFP
2 when not expressing lytic gene products. The HCMV
IE1 promoter was therefore regulated independently of the rest of
the MHV-68 genome. At least as many cells must be infected as
are BAC-eGFP
+, but BAC-eGFP expression did not identify all
infected cells and emphatically did not distinguish lytic from latent
infection. This limitation needs to be borne in mind for the
HCMV IE1-driven transcription of any antigen or marker protein
from the MHV-68 genome. In contrast, gM-eGFP expression
allowed us specifically to identify lytically infected DCs.
MHV-68 is mainly latent in bone marrow-derived
DCs
MHV-68 virions with eGFP-tagged gM are sufficiently fluorescent
to be detected on or in infected cells even without new viral gene
expression [32]. In Fig. 1B, at least 90% of DCs had endocytosed
enough gM-eGFP
+ virions for low-level fluorescence (compare
with uninfected cells), but only 30% supported new lytic gene
expression. The fraction of cells showing lytic gene expression
increased with time and most of the DCs in infected cultures died
within 2 weeks. This argued against abortive infection, and
suggested that the majority of MHV-68-exposed DCs become
latently infected but that their virus then quite rapidly reactivates.
Infected BAC-eGFP
2 macrophages can be revealed by LPS
treatment, which activates the HCMV IE1 promoter [38]. With
an infection multiplicity of 3PFU/cell, LPS induced BAC-eGFP
expression in almost all MHV-68-exposed, MHC class II
lo DCs
(Fig. 3A). Only MHC class II
hi DCs remained eGFP
2, suggesting
that these were not infected. These DCs also remained gM-eGFP
2
(Fig. 3A). Unlike BAC-eGFP
+ DCs, gM-eGFP
+ DCs largely
disappeared within 6 h of LPS treatment. The activation of
HCMV IE1 transcription by LPS therefore did not indicate a shift
to MHV-68 lytic infection - if anything, the opposite, as lytic
infection seemed incompatible with LPS stimulation. Immunoflu-
orescence confirmed that LPS treatment led to a complete loss of
lytically infected DCs (Fig. 3B). The only gM-eGFP fluorescence
left was limited and localized, the pattern of endocytic uptake
rather than new gene expression (Fig. 2B). The significance of the
LPS-triggered death of lytically infected DCs is unclear - these
stimuli are hardly a physiological combination - but it made clear
that the functional effect of such stimuli on virus-exposed DCs
MHV-68 in DCs
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expression. It appeared that an infection multiplicity of 3PFU/
cell infected all immature DCs, the majority latently, while very
few mature DCs were infected.
As a further measure of latent infection we generated MHV-68
with eGFP-tagged ORF73 - its episome maintenance protein
[42,43]. ORF73 is not necessarily transcribed in every latently
infected cell - transcription of the functionally homologous EBNA-
1 is linked to cell division [44] - but it is currently the best available
marker. EGFP fluorescence was faint (Fig. 3C), but almost all
(.90%) the DCs exposed to eGFP-ORF73 MHV-68 (3PFU/cell)
showed punctate nuclear fluorescence, consistent with the
distribution of the homologous KSHV ORF73 [45]. All DCs
with nuclear ORF65 staining (lytic infection) were also eGFP-
ORF73
+, but most eGFP-ORF73
+ DCs were ORF65
2. The
eGFP-ORF73
+ORF65
2 DCs were presumably latently infected.
Again, with an infection multiplicity of 3PFU/cell, the only eGFP-
ORF73
2 cells were those with high MHC class II expression
(Fig. 4A). Interestingly, the lytically and latently infected MHC
class II
lo cells all became adherent. Thus, in uninfected cultures
both mature and immature DCs were largely non-adherent, with
90% of the non-adherent DCs being immature; but in infected
cultures, only the mature (uninfected) DCs remained non-
adherent (Fig. 4A). This did not reflect an increase in maturation,
but rather a selective adherence to plastic of the immature,
infected DCs.
We addressed the infectibility of mature DCs further by
exposing immature DCs to LPS or not 5 h before exposing them
to MHV-68 (Fig. 4B). In contrast to the immature DCs, the LPS-
matured DCs failed to express either BAC-eGFP or gM-eGFP.
Figure 1. Direct identification of lytically infected DCs. A. Cells grown from C57BL/6 mouse bone marrow with GM-CSF were tested for cell surface
expression of dendritic cell markers by flow cytometry, with or without 6 h LPS treatment (250 ng/mL). The data are from 1 of 5 equivalent
experiments. B. Equivalent cells to A were left uninfected or infected with MHV-68 (3PFU/cell, 22 h) expressing eGFP either from a human
cytomegalovirus IE1 promoter (BAC-eGFP) or fused to the endogenous gM C-terminus (gM-eGFP). Infection was evaluated by flow cytometric assay
of eGFP expression. The percentage of cells in each quadrant is shown. The data are from 1 of 5 equivalent experiments. C. Equivalent cells to A were
left uninfected or infected with gM-eGFP MHV-68 (3PFU/cell, 22 h). Infections were done in the presence of 100 mg/ml heparin, 0.1% MHV-68-
immune rabbit serum or 100 mg/ml phosphonoacetic acid (PAA) as shown. Infection was assessed by flow cytometric assay of gM-eGFP expression.
doi:10.1371/journal.pone.0001048.g001
MHV-68 in DCs
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resisted MHV-68 infection.
Lytically infected DCs down-regulate MHC class I-
restricted antigen presentation
A key aspect of the MHV-68-infected DC phenotype is MHC class
I-restricted antigen presentation. The MHV-68 M3 can inhibit
CD8
+ T cell migration [46], but only K3 has been shown to
inhibit CD8
+ T cell recognition [7]. In order to compare K3
+ and
K3
2 gM-eGFP
+ viruses, we truncated K3 after its first trans-
membrane domain in the gM-eGFP BAC (Fig. 5A). This
inactivates it completely [8]. Southern blots confirmed the
predicted loss of an ApaI site in the deleted K3 segment, as well
as the diagnostic BamHI site between gM and its C-terminal eGFP
tag (Fig. 5A). The growth of K3
+ and K3
2 gM-eGFP mutants was
indistinguishable from that of wild-type MHV-68 (Fig. 5B). As
expected, K3 disruption increased lytic antigen presentation by
fibroblasts infected with gM-eGFP MHV-68, much like a K3
knockout on the wild-type BAC background (Fig. 5C).
Lytically infected (gM-eGFP
hi) DCs down-regulated MHC class
I expression relative to uninfected or latently infected (gM-eGFP
lo)
DCs (Fig. 5D). This down-regulation was K3-dependent, as it was
not seen with the gM-eGFP K3
2 mutant. DCs infected with the
K3 mutant also showed better lytic antigen presentation than
those infected with wild-type (Fig. 5E). Exogenous peptide was
presented much the same, consistent with latently infected DCs
not expressing K3. A comparison of the infected cells and peptide-
pulsed cells in Fig. 5E indicated that K3 reduced endogenous p56
presentation approximately 10-fold. The non-zero antigen pre-
sentation of K3
+ MHV-68 in Fig. 5E was unsurprising. Not only is
K3 unlikely to be 100% efficient, but non-lytic DCs can
presumably still cross-present the virion and infected cell debris.
This result emphasizes that K3 is unlikely to have global effect on
immune priming in MHV-68 infection. It acts mainly to disguise
lytically infected DCs.
K3 protects lytically infected DCs against CD8
+ T
cell-mediated lysis
To test further the impact of K3 on CD8
+ T cell recognition of
lytically infected DCs, we made use of the fact that the MHV-68
p56 epitope-specific hybridoma 49100.2 retains cytotoxic effector
function. We infected DCs overnight with K3
2 or K3
+ gM-eGFP
viruses, added hybridoma cells with or without 20 nM p56 peptide
for a further 7 h, then counted the ORF65
+gM-eGFP
+ cells
remaining (Fig. 6). K3 expression substantially protected lytically
infected cells against recognition by 49100.2 T cells unless
exogenous peptide was also added.
In contrast to the antigen presenting defect of lytically infected
DCs, unfractionated MHV-68-infected DC cultures processed and
presented exogenous ovalbumin fairly normally to both I-E
d-
restricted DO.11.10 T cells and H2-K
b-restricted OT-I T cells
(Fig. 7). This illustrates how mixed culture results can be
misleading. It was clear that without establishing reasonably
uniform viral gene expression in the population under study, only
very limited conclusions can be drawn about viral gene functions.
MHV-68 down-regulates CD86 expression on
lytically infected DCs
We also looked for lytic cycle down-regulation of other DC
molecules involved in antigen presentation (Fig. 8A). CD80 was
unaffected by MHV-68 infection. However, CD86 expression was
noticeably less on gM-eGFP
hi cells than on uninfected or gM-
eGFP
lo. Even ignoring the DCs with high CD86 expression, which
resist MHV-68 infection (Fig. 4), CD86 expression was clearly less
Figure 2. Correlating BAC-eGFP and gM-eGFP expression with other markers of MHV-68 lytic infection in DCs. A. DCs were plated onto coverslips
and infected (3PFU/cell, 22 h) with BAC-eGFP or gM-eGFP MHV-68 as shown, then fixed, permeabilized and stained for the ORF65 capsid component
with mAb MG-12B8. Nuclei were visualized with DAPI. The data are from 1 of 3 equivalent experiments. B. DCs were infected (3PFU/cell) with gM-
eGFP MHV-68 and then washed and fixed after 4 h or 24 h before staining for ORF65 as in A. The data are from 1 of 3 equivalent experiments. C. DCs
were infected as in A and stained for ORF75a with mAb BN-3H8 The data are from 2 of 3 equivalent experiments. D. DCs were infected with gM-eGFP
MHV-68 as in A and stained for gN with mAb 3F7 or for thymidine kinase with mAb CS-4A5. The data are from 1 of 2 equivalent experiments.
doi:10.1371/journal.pone.0001048.g002
MHV-68 in DCs
PLoS ONE | www.plosone.org 5 October 2007 | Issue 10 | e1048on the gM-eGFP
hi cells compared to gM-eGFP
2 and gM-eGFP
lo.
gM-eGFP
hi cells also down-regulated MHC class II expression
somewhat relative to gM-eGFP
lo cells. Neither effect was due to
K3 (data not shown).
We tested further whether LPS or IFN-c might influence CD86
or MHC class II expression on lytically infected DCs (Fig. 8B).
IFN-c upregulated CD86 on uninfected but not gM-eGFP
hi
(lytically infected) DCs. gM-eGFP
lo DCs responded weakly.
These DCs are probably latently infected: they correspond to
those in Fig. 2B that have endocytosed virions but not yet
initiated lytic infection, and to the DCs in Fig. 3C that are
eGFP-ORF73
+ORF65
2. LPS upregulated MHC class II and
CD86 expression on both uninfected and gM-eGFP
lo cells. Its
main effect on gM-eGFP
hi cells was, as in Fig. 3, to trigger their
destruction. Thus, latently infected DCs responded fairly normally
to LPS but were impaired in their response to IFN-c. Lytically
infected DCs responded abnormally to both: IFN-c had no effect
and LPS triggered cell death.
DISCUSSION
Herpesvirus latency and lytic replication are very different states,
so the first step in defining infected DC phenotypes must be to
Figure 3. Identification of latent MHV-68 in DCs. A. DCs were infected with BAC-eGFP or gM-eGFP MHV-68 (3PFU/cell, 18 h), then treated or not
with LPS (250 ng/mL) for 6 h. CD11c
+ cells were then analyzed for eGFP expression and cell surface MHC class II expression by flow cytometry. The
data are from 1 of 3 equivalent experiments. B. DCs were plated onto coverslips then infected with gM-eGFP MHV-68 and exposed or not to LPS as in
A. EGFP expression was visualized directly and nuclei counterstained with DAPI. The data are from 1 of 3 equivalent experiments. C. DCs were
infected (3PFU/cell, 22 h) with MHV-68 expressing eGFP-tagged ORF73, then examined by confocal microscopy. Essentially every adherent cell
expressed some nuclear eGFP, although the precise staining pattern differed between individual cells. The data are from 1 of 3 equivalent
experiments. D. Cells were infected with eGFP-ORF73 MHV-68 as in C, then stained for the ORF65 capsid component with mAb MG-12B8. The data
are from 1 of 2 equivalent experiments.
doi:10.1371/journal.pone.0001048.g003
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MHV-68 established a predominantly latent infection in imma-
ture, bone marrow-derived DCs, much as it does in peritoneal
macrophages [38]. Latency was not stably maintained, and viral
reactivation killed most of the DCs in infected cultures over a few
days. Lytically infected DCs showed a K3-dependent inhibition of
MHC class I-restricted antigen presentation, a K3-independent
down-regulation of CD86 expression, and a highly abnormal
response to activation signals. Conclusions about latency must be
more guarded. We found that latently infected DCs respond
poorly to IFN-c but fairly normally to LPS, at least over a 6 h time
frame. Thus, it was clear that latent infection disrupts DC
responses much less than lytic infection does, but MHV-68 latency
may encompass more than one viral gene expression program.
Understanding the latently infected DC phenotype requires
a better definition of viral gene expression.
Hochreiter et al. found that MHV-68 inhibits DC responses to
maturation signals [47], but they did not distinguish lytic from
latent infection, so whether they observed mainly the lytic or the
latent infection phenotype is unclear. Specifically, our data
contradict their assumption that transcription from an HCMV
IE1 promoter at the left end of the MHV-68 genome corresponds
to lytic infection. Instead, this promoter was regulated indepen-
dently of endogenous viral gene expression. This has important
implications for studies that use HCMV IE1 promoters to drive
MHV-68 gene expression in vivo. MHV-68 specifically protects its
episome maintenance protein from MHC class I-restricted antigen
presentation [18]. An HCMV IE1 promoter would give gene
expression independent of such evasion and could therefore make
latently infected cells vulnerable to immune elimination, in-
dependent of the function of the gene being expressed.
Bone marrow-derived DC cultures exposed to MHV-68
contained not only lytic and latent infections, but also uninfected
cells. Specifically, mature DCs (MHC class II
hiCD86
hi) showed
neither gM-eGFP expression (indicative of lytic infection), eGFP-
ORF73 expression (lytic or latent infection) nor LPS-inducible
BAC-eGFP expression (independent of MHV-68 gene expression).
Thus, while immature DCs were either lytically or latently
infected, mature DCs were largely uninfected, perhaps because
they drastically reduce endocytosis [48], the route by which MHV-
68 normally infects [49]. The presence of mature, uninfected DCs
in infected cultures obviously makes assays that do not distinguish
between latent infection and no infection very hard to interpret.
Our finding that K3 disruption markedly enhances lytic epitope
presentation contradicts the speculation of Flano et al. that K3
does not work in DCs. It seems likely that Flano et al. and
Hochreiter et al. both failed to notice K3 function in DCs because
they did not distinguish lytic from latent infection. The lytic
antigen presentation observed by Flano et al. emphasizes further
the problem of using in vitro assays as absolute measures, rather
than to compare wild-type and knockout viruses (or DCs).
Immune evasion is rarely absolute, and cell debris and defective
virus particles provide abundant antigen for cross-presentation.
Some T cell response is therefore unsurprising. Without a suitable
comparison, its significance is easily over-interpreted.
How do the MHV-68-infected DC phenotypes fit with what we
know of pathogenesis? It is unlikely that DC infection has much
globaleffectonantigenpresentation.RelativelyfewDCsareinfected
[23], so cross-priming should still operate. Indeed, the magnitude of
acute, MHV-68-specific CD8
+ T cell responses is quite in keeping
with that made to other viral infections [24]. K3-deficient MHV-68
stimulates stronger CD8
+ T cell responses than wild-type [20], but
this is as likely to reflect more stimulation of primed cells as more
priming. Herpesviruses seem to rely mainly on effector cell evasion.
Thus, rather than limiting immune priming K3 may help lytically
infected DCs to evade CD8
+ T cell recognition once priming has
occurred. What might lytic DC infection contribute to pathogenesis
Figure 4. No sign of MHV-68 infection in mature DCs. A. DCs were left
uninfected or exposed to gM-eGFP, BAC-eGFP or eGFP-ORF73 MHV-68
(3PFU/cell, 22 h). The non-adherent cells were centrifuged onto cover
slips, then stained for MHC class II expression and also examined for
eGFP expression/uptake. The data are from 1 of 2 equivalent
experiments. B. Bone marrow-derived DCs were incubated or not with
LPS to trigger maturation, then exposed to BAC-eGFP
+ or gM-eGFP
+
MHV-68 as shown (3PFU/cell). 22 h later, CD11c
+ cells were analyzed for
surface MHC class II expession and virus-driven eGFP.
doi:10.1371/journal.pone.0001048.g004
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first transmembrane domain. Wild-type, K3
+gM-eGFP and K3
2gM-eGFP viruses were analyzed by Southern blotting. The predicted alterations to the gM
andK3 lociareshown.Thus,gM-eGFPinsertiondonwstreamofgM introducesa BamHIrestrictionsitesuchthatthe10 kbgenomicBamHIfragmentiscut
into4.1 kband 6.6 kbfragments. TheK3 deletionremoves anApaI site, such that1.7 kband 1.9 kbgenomicfragmentsare combined intoa single3.4 kb
fragment. B. BHK-21 cells were infected (0.01PFU/cell) as indicated. Replicate cultures were frozen at each time point. All were then assayed for virus titer
by plaque assay. C. H2
b MEF-1 fibroblasts were left uninfected or infected (2PFU/cell, 4 h) with K3
+ or K3
2 gM-eGFP viruses or a gM-eGFP
2 K3 mutant
(K3
2TET
+) [20]as a control. The cells were then washed and incubated overnight with the 49100.2 T cell hybridoma, which recognizes anH2-D
b-restricted
MHV-68 lytic epitope and produces b-galactosidase upon activation. The cells were lysed in 1% NP-40 and beta-galactosidase activity measured with
CPRG. Each bar shows mean 6 SD absorbance readings from triplicate cultures. The data are from 1 of 3 equivalent experiments. D. DCs were infected
(3PFU/cell, 22 h) with K3
+ or K3
2 gM-eGFP MHV-68 as indicated, then and stained for cell surface H2-K
b expression and eGFP expression by flow
cytometry.Each graphshows gated CD11c
+ cells. In the dot plots, the number shows the percentage of all CD11c
+ cells in each quadrant. The histograms
showequivalentdata,but gatedaccordingtohighor lowgM-eGFP expression. Thedataarefrom 1 of3 equivalentexperiments. E.H2
b DCs wereinfected
with K3
+ or K3
2 viruses as indicated for 4 h, washed and incubated overnight with the MHV-68 p56-specific 49100.2 T cell hybridoma. b-galactosidase
expression was then measured with CPRG. Mean 6 DC absorbance values of triplicate cultures are shown. Duplicate samples were coated with reducing
concentrations of p56 peptide and assayed as above. The data are from 1 of 3 equivalent experiments.
doi:10.1371/journal.pone.0001048.g005
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probably get infected in peripheral sites, where viral lytic replication
isabundant[26].DCmigrationtodraininglymphnodesfollowedby
viral reactivation would then be one way to infect B cells [50].
Lytically infected DCs may also secrete the M3 chemokine binding
protein to provide bystander protection for latently infected B cells
[51]. In both settings, a lack of K3 would impair latency
establishment by predisposing lytically infected DCs to immune
elimination. This could in part explain the latency amplification
deficitofK3-deficientmutants.Evenwhenaninvivophenotypeand
a biochemicalfunction areknown,itwouldseem that linking thetwo
is not necessarily straightforward.
Figure 6. K3-dependent CD8
+ T cell evasion by MHV-68-infected DCs.
A. H2
b DCs were infected (3PFU/cell, 16 h) with K3
+ or K3
2 gM-eGFP
MHV-68 viruses and then co-cultured with the H2-D
b-restricted, p56-
specific 49100.2 hybridoma cells with or without 20 nM p56 peptide for
a further 6 h. The DCs were then washed, fixed and stained for ORF65
capsid expression with mAb MG-12B8. The hybridoma cells are partially
adherent, so where hybridoma cells were added they may contribute to
the DAPI staining. B. Mean 6 SD values of gM-eGFP
+ cell counts in
randomly selected fields (.20 each). Each number is expressed relative
to the number for infection without hybridoma cells. Thus, ‘‘20%’’
means that the treatment arm had 20% the number of eGFP
+ cells per
field seen when hybridoma cells were not added. The data are from 1 of
3 equivalent experiments.
doi:10.1371/journal.pone.0001048.g006
Figure 7. Antigen presentation by mixed infected DC cultures. A. H2
d
DCs were infected with MHV-68 (3PFU/cell, 18 h). Ovalbumin was then
added to the DCs for 2 h and removed. DO.11.10 hybridoma cells
(CD4
+, ovalbumin-specific, IA
d-restricted) were then added for a further
15 h. IL-2 in cell supernatants was then measured by ELISA. Each bar
shows mean 6 SD values of triplicate cultures. The data are from 1 of 3
equivalent experiments. B. H2
b DCs were infected with MHV-68 (3PFU/
cell, 24 h). Ovalbumin was then added to the DCs for 6 h and removed.
CFSE-labelled OT-I transgenic T cells from lymph nodes (CD8
+,
ovalbumin-specific, H2-K
b-restricted) were then added for a further
3 d. The fraction of proliferating CD8
+ cells (based on loss of CFSE
staining) was then determined by flow cytometry. The data are from 1
of 3 equivalent experiments.
doi:10.1371/journal.pone.0001048.g007
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